Hernexeos (Zongertinib)

 Hernexeos (zongertinib) is a kinase inhibitor used for the treatment of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain activating mutations, and who have previously been treated with systemic therapy.

Note: This indication is approved under accelerated approval based on objective response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Recommended Dosage:
The recommended dosage of Zongertinib is taken orally once daily with or without food until there is evidence of disease progression or unacceptable toxicity. Swallow the tablets whole with water. It is not advisable to split, crush, or chew tablets.
The dosage based on body weight:

• < 90 kg: 120 mg
• ≥ 90 kg: 180 mg

If a dose is missed within 12 hours, take the dose. If a dose is missed by more than 12 hours, skip the missed dose and take the next scheduled dose. If any dose is vomited, do not take an additional dose. Take the next dose at the regularly scheduled time.

• Zongertinib 60 mg may result in severe liver issues. Liver function tests should be performed on patients both before and during treatment. You need medical attention if you have symptoms like yellow skin, dark urine, nausea, or right abdominal pain. It might be necessary to change the dosage or stop the treatment.
• This medication may have an impact on the heart’s ability to pump blood. Echocardiograms are necessary for close monitoring of patients with a history of heart disease. You should notify a healthcare provider right away if you experience symptoms like shortness of breath, foot swelling, or unusual fatigue.
• Rarely, zongertinib may result in severe lung inflammation. Any new or worsening cough, breathing issues, or chest pain should be reported immediately by the patient. Zongertinib should be discontinued, and appropriate medical attention should be provided if interstitial lung disease or pneumonitis is confirmed.
• An unborn child may be harmed by zongertinib 60 mg tablets. Effective contraception should be used by women who are capable of becoming pregnant both during and after their last dose of treatment. Women who are pregnant should not take this medication and should speak with their doctor about safe substitutes.
• Although the possibility of Zongertinib passing into breast milk is unknown, infants may be at risk. As recommended by their treating healthcare provider, women should refrain from breastfeeding while taking this medication and for a few days following the last dosage.

What documents are required to import HERNEXEOS to India?

HERNEXEOS (zongertinib) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is HERNEXEOS available in India?

HERNEXEOS (zongertinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Hernexeos in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

HERNEXEOS can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of HERNEXEOS (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork-in-253190.hostingersite.com for Hernexeos tablets 60 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source HERNEXEOS (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Hernexeos®?

Zongertinib is the Generic Name for the trade name drug Hernexeos®.

What is the Manufacturer’s Name of Hernexeos®?

Hernexeos® is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Is Hernexeos approved by the FDA?

Yes. Hernexeos is approved by the FDA. Date of first approval: August 8, 2025.

What is the dosage and form of Hernexeos® supplied?

Hernexeos is supplied as tablets: 60 mg for oral administration.

What are the most common side effects of Hernexeos® Tablets?

The most commonly reported side effects of Hernexeos® are diarrhea, fatigue, hepatotoxicity, rash, and nausea.

How much does Hernexeos® Tablets cost in India?

Hernexeos® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Hernexeos prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Hernexeos tablets 60 mg cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork-in-253190.hostingersite.com.

Can Hernexeos® 60 mg tablets be available in SAARC countries?

Apart from Gulf countries, Hernexeos® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Hernexeos® tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Hernexeos® tablets online in India?

Yes, one can buy Hernexeos 60 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Hernexeos® tablets through legal channels.

What are the storage conditions of Hernexeos® 60 mg Tablets?

Store tablets at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store this oral medicine in the original container to protect it from moisture. Keep the bottle well closed.